Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Challenges and opportunities of using omics in EDC research

Published byMari Kähkönen Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 1 Challenges and opportunities of using omics in EDC research"— Presentation transcript:

1 Figure 1 Challenges and opportunities of using omics in EDC research
Figure 1 | Challenges and opportunities of using omics in EDC research. Schematic representation of the sequence of steps from production of chemicals to endocrine-disrupting chemical (EDC) exposure, from toxicological research to human studies, and from challenges with exposure characterization and risk prediction to the anticipated goals and opportunities of applying genomics, epigenomics and mitochondriomics to the field of EDC research. mtDNA, mitochondrial DNA. Messerlian, C. et al. (2017) ‘Omics’ and endocrine-disrupting chemicals — new paths forward Nat. Rev. Endocrinol. doi: /nrendo

Download ppt "Figure 1 Challenges and opportunities of using omics in EDC research"

Similar presentations

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Electromechanical properties of OIHPs

Figure 2 Electromechanical properties of OIHPs
Figure 6 Selected examples of TERS applications in material systems

Figure 6 Selected examples of TERS applications in material systems
Figure 3 Childhood craniopharyngioma

Figure 3 Childhood craniopharyngioma
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 2 Regions of Africa exposed to undernutrition

Figure 2 Regions of Africa exposed to undernutrition
Figure 7 Mendelian randomization of overlapping exposures

Figure 7 Mendelian randomization of overlapping exposures
Figure 2 Pathophysiology of hyperglycaemia in T2DM

Figure 2 Pathophysiology of hyperglycaemia in T2DM
with undiagnosed diabetes mellitus by three diagnostic criteria

with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 4 Amino acid structure of short-acting and long-acting insulins

Figure 4 Amino acid structure of short-acting and long-acting insulins
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Adverse effects in women treated with HRT

Figure 1 Adverse effects in women treated with HRT
Figure 1 Monogenic forms of diabetes mellitus

Figure 1 Monogenic forms of diabetes mellitus
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Circadian and ultradian fluctuations in corticosterone

Figure 2 Circadian and ultradian fluctuations in corticosterone
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Similar presentations

Ads by Google